Entities / Company
Seagen.
American biotechnology company
- Reports this week
- 0
- Active events
- 0
- Connections
- 27
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
-
Pfizer and Seagen are growing their older-adult vaccine market share by expanding the Prevnar 20 vaccination program and rebuilding their commercial model around acquired products.Some support1 report
-
Pfizer acquired Seagen for its cancer drug candidates, while a separate deal with Innovent helps offset revenue decline.Some support2 reports
-
Pfizer is developing the drug berobenatide for future growth, referencing its 2023 acquisition of Seagen.Some support3 reports
-
Pfizer acquired Biohaven Pharmaceuticals, Seagen, and Arena Pharmaceuticals in transactions dating back to 2022.Some support2 reports1 development inside
-
Ganeshalingam, who worked at Seagen before Pfizer, is a member of both the American and European Societies for Medical Oncology.Some support1 report
Gone quiet
No new reports in 90+ days-
Pfizer acquired Seagen in a pivotal transaction.Well supported4 reports1 development inside
-
Pfizer cut its dividend to fund the Wyeth deal while facing debt pressure from the Seagen acquisition.Some support2 reports
-
Pfizer received FDA approval for its IBRANCE regimen, while analyst commentary included a price target cut from Bank of America and an upgrade from Royal Bank of Canada. Separately, Nike appointed David Denton as its next CFO.Some support3 reports
-
A 2025 acquisition strengthened Pfizer's oncology position, involving Seagen, AstraZeneca, and Merck.Some support4 reports
No events began in the chosen period. Widen it, or reset.
Around Seagen this week
News at the entities that move Seagen most-
Pfizer StructuralPepsiCo, Meta, Toyota, Google, and Pfizer contributed founding council members to the Peerworks initiative led by Zero100.Moves Seagen
-
Hoffmann-La Roche Mentioned togetherFDA approved a GSK drug and authorized a Roche blood test for eligibility, amidst estimates of 1.7M chronic HBV patients in the US.Moves Seagen
Connections
The 3 strongest of 27, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Pfizer Structural
Pfizer acquired Seagen in 2023 and integrated it as a subsidiary to bolster its oncology portfolio.
-
Hoffmann-La Roche Mentioned together
Both Seagen and Hoffmann-La Roche are identified as companies operating within the pharmaceutical and biotech sectors.
-
Dave Denton Transactional
Dave Denton oversaw transactions involving Seagen.
History
Events by the month they beganSeptember 2026
2 eventsAugust 2026
1 eventJune 2026
6 events- Pfizer acquired Seagen for its cancer drug candidates, while a separate deal with Innovent helps offset revenue decline.
- Pfizer acquired Biohaven Pharmaceuticals, Seagen, and Arena Pharmaceuticals in transactions dating back to 2022.
- Pfizer acquired Seagen in a pivotal transaction.
- Pfizer cut its dividend to fund the Wyeth deal while facing debt pressure from the Seagen acquisition.
- Pfizer received FDA approval for its IBRANCE regimen, while analyst commentary included a price target cut from Bank of America and an upgrade from Royal Bank of Canada. Separately, Nike appointed David Denton as its next CFO.
- A 2025 acquisition strengthened Pfizer's oncology position, involving Seagen, AstraZeneca, and Merck.